ETHNIC-DIFFERENCES IN DRUG DISPOSITION AND RESPONSIVENESS

被引:148
作者
WOOD, AJJ
ZHOU, HH
机构
[1] Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
关键词
D O I
10.2165/00003088-199120050-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Interethnic differences are important factors accounting for interindividual variations in drug responsiveness. However, these differences in drug response have been a relatively neglected area of investigation, so that similar doses are prescribed to different ethnic populations without consideration of interethnic pharmacokinetic and pharmacodynamic variation. With the increased recognition of genetically determined polymorphism in metabolising ability as an important factor in drug disposition, concern has developed for the importance of individualising drug dose to account for racial differences. The recognition of these differences in drug disposition and responses calls into question the failure of drug licensing authorities to demand information on dosage, efficacy and toxicity in different ethnic groups, and to accept data from limited ethnic groups such as Caucasians. This article reviews the evidence for ethnic differences in drug disposition and sensitivity and should encourage further investigations to elucidate the extent of such differences, their causes and their therapeutic impact.
引用
收藏
页码:350 / 373
页数:24
相关论文
共 184 条
[21]   A KINETIC STUDY OF DRUG ELIMINATION - EXCRETION OF PARACETAMOL AND ITS METABOLITES IN MAN [J].
CUMMINGS, AJ ;
KING, ML ;
MARTIN, BK .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :150-&
[22]   CONTRIBUTION OF THE GENETIC STATUS OF OXIDATIVE-METABOLISM TO VARIABILITY IN THE PLASMA-CONCENTRATIONS OF BETA-ADRENOCEPTOR BLOCKING-AGENTS [J].
DAYER, P ;
BALANT, L ;
KUPFER, A ;
COURVOISIER, F ;
FABRE, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (06) :797-799
[23]  
DAYER P, 1982, LANCET, V1, P509
[24]  
DEVADATTA S, 1960, Bull World Health Organ, V23, P587
[25]  
DICK B, 1982, SCHWEIZ MED WSCHR, V112, P1061
[26]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[27]   GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN NEGRO + JAPANESE POPULATIONS [J].
DUFOUR, AP ;
KNIGHT, RA ;
HARRIS, HW .
SCIENCE, 1964, 145 (363) :391-&
[28]  
EDWARDS JA, 1967, CLIN PHARMACOL THER, V8, P824
[29]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[30]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186